EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stereotactic Radiation Therapy or Protons for Uveal Melanoma Patients? An Artificial Intelligence (AI)-Based Clinical Treatment Decision-Making Tool Predicting Doses To Radiation Therapy Constraints

Emmanuelle Fleury, Jean-Philippe Pignol, Emine Kiliç, Caroline van Rij, Nicole Naus, Serdar Yavuzyigitoglu, Wilhelm den Toom, Andras Zolnay, Kees Spruijt, Marco van Vulpen, Petra Trnková, Mischa Hoogeman

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.06.3867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Emmanuelle Fleury und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Erasmus Medical Center Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Holland Proton Therapy Ce…. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Proton Therapy, Artificial Intelligence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Institute for Health Services Research, Varian Medical Systems Inc, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: For ocular melanoma, selecting between stereotactic radiation therapy (SRT) and protons requires a lengthy plan comparison process. The purpose of this brief report is to describe an artificial intelligence (AI) decision-making tool to predict dosimetric and clinical outcomes based on easy-to-access tumor characteristics. METHODS AND MATERIALS: The AI tool was based on a retrospective database of 66 patients with uveal melanoma treated in a single center with robotic SRT. A supervised machine learning model was developed to correlate the risk of toxicity for each radiation modality and clinical features. Clinical toxicity risks were built in various profiles: Profile I for maculopathy, optic-neuropathy, and visual acuity deterioration; Profile II for neovascular glaucoma; Profile III for radiation-induced retinopathy; and Profile IV for dry-eye syndrome. RESULTS: Machine learning-based toxicity prediction accuracy for selecting the correct treatment modality was 81%, 77%, 91%, and 93% for Profiles I, II, III, and IV, respectively. CONCLUSION: The study shows that a machine learning method based on easy-to-access clinical characteristics can predict which toxicity would be greater with SRT or protons. This AI tool could support patients in making informed treatment decisions in an ophthalmology clinic, without the lengthy wait for computed tomographic simulation results and extensive plan comparisons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaUveal NeoplasmsProton TherapyArtificial IntelligenceRadiosurgeryClinical Decision-MakingMachine LearningHumansUveal MelanomaRetrospective StudiesMaleMiddle AgedFemaleAgedRadiotherapy DosageAged, 80 and overAdultRadiation Injuries

Autor:innen und Institutionen

  • Department of Radiotherapy, Erasmus Medical Center Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Holland Proton Therapy Center, Delft, The Netherlands. Electronic address: e.fleury@erasmusmc.n…
  • Sultan Qaboos Comprehensive Cancer and Research Center, Muscat, Oman.
  • Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Department of Radiotherapy, Erasmus Medical Center Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Holland Proton Therapy Center, Delft, The Netherlands.

Förderung

  • Netherlands Institute for Health Services Research
  • Varian Medical Systems Inc
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Stichting voor de Technische Wetenschappen

Zitieren

APA

Fleury, E., Pignol, J. P., Kiliç, E., van Rij, C., Naus, N., Yavuzyigitoglu, S., den Toom, W., Zolnay, A., Spruijt, K., van Vulpen, M., Trnková, P., & Hoogeman, M. (2025). Stereotactic Radiation Therapy or Protons for Uveal Melanoma Patients? An Artificial Intelligence (AI)-Based Clinical Treatment Decision-Making Tool Predicting Doses To Radiation Therapy Constraints. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.06.3867

Vancouver

Fleury E, Pignol JP, Kiliç E, van Rij C, Naus N, Yavuzyigitoglu S, et al. Stereotactic Radiation Therapy or Protons for Uveal Melanoma Patients? An Artificial Intelligence (AI)-Based Clinical Treatment Decision-Making Tool Predicting Doses To Radiation Therapy Constraints. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.06.3867

BibTeX
@article{Fleury2025,
  author = {Fleury, Emmanuelle and Pignol, Jean-Philippe and Kiliç, Emine and van Rij, Caroline and Naus, Nicole and Yavuzyigitoglu, Serdar and den Toom, Wilhelm and Zolnay, Andras and Spruijt, Kees and van Vulpen, Marco and Trnková, Petra and Hoogeman, Mischa},
  title = {Stereotactic Radiation Therapy or Protons for Uveal Melanoma Patients? An Artificial Intelligence (AI)-Based Clinical Treatment Decision-Making Tool Predicting Doses To Radiation Therapy Constraints},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.06.3867}
}
Kostenlos starten →